- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
A capital increase in kind is to finance the equity investment in sarastro, previously a cooperation partner
Nanogate (ISIN DE000A0JKHC9), a leading international nanotechnology enabler, has formally completed the capital increase as announced. The 5,000 new shares have now been entered in the commercial register, taking the total number of shares in Nanogate AG to 1,905,000. In December 2009 Nanogate had announced its intention to acquire a 25.1 % stake and an option for the majority of shares in sarastro GmbH. The purchase price is a low six-figure euro amount and consists of cash and share components. With this investment Nanogate has added biocompatible solutions to its technology portfolio. The nanotechnology company sarastro specialises in producing antimicrobial and medically tolerable surfaces. The first joint product is now available commercially.
Nanogate and sarastro together intend to equip materials, surfaces and products for a wide variety of applications with new biological properties, creating high-performance solutions for a rapidly growing market. The first joint project is the technology platform permaProtect Membran, which for the first time combines antimicrobial, breathable and moisture-controlling properties in one membrane. This new technology is the basis for an order received by Nanogate to manufacture initial products that offer improved hygienic properties and greater comfort. It comes from a leading European shoe retailer.
In 2009 sarastro reported a high six-figure euro sum in sales and achieved break-even. sarastro's technology is used for instance in hearing aids from Siemens and a leading Swiss manufacturer, as well as in filtration systems for drinking water purification and in PVC air and water hoses. The company also produces disinfectants and other fluids with a patented technology that enables an especially long-lasting disinfectant and antimicrobial action.
This publication constitutes neither an offer to sell nor an invitation to buy securities. The shares in Nanogate AG (the "Shares") may not be offered or sold in the United States or to or for the account or benefit of "U.S. persons" (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "Securities Act")). No offer or sale of transferable securities is being made to the public outside Germany.
About Nanogate AG
Nanogate is a leading international enabler in the nanotechnology growth market and so opens the gate to this technology for its customers. The firm, which is based in Göttelborn (Saarland), enables the programming and integration of additional properties – such as non-stick, anti-bacterial, anti-corrosive and ultra-low friction – into materials and surfaces. Nanogate thereby gains a competitive edge for its customers by product refinement using chemical nanotechnology. Nanogate covers a wide range of industries, functions and substrates on the basis of technology platforms. The company thus provides a decisive interface for the commercial use of chemical nanotechnology and bridges the gap between the suppliers of raw materials and industrial conversion into products. In doing so, Nanogate concentrates as an enabler on one of the most attractive segments in the industry. As a partner in innovation, Nanogate provides many services along the value chain – from development and production of innovative nanocomposities and nanostructured materials to powerful support for innovation and product integration.
The Nanogate Group currently has 82 employees in all (as of April 2010) and since commencing operations in 1999 has been a trailblazer in nanotechnology. The company has first-class customer references (e.g. ABB, BSH Bosch-Siemens Haushaltsgeräte, Kärcher, Koenig & Bauer AG, Opel and REWE Austria) and many years’ experience of different industries and applications. To date, more than 180 projects have gone into mass production. Nanogate has also entered into strategic cooperations with international companies such as the GEA Group and Dow Corning. The Group also includes Nanogate Advanced Materials GmbH, which specialises in complex applications like high-performance optics, FNP GmbH in the area of sport/leisure, a majority shareholding in Holmenkol AG and a shareholding in sarastro GmbH.
Innovation-driven competitive advantage
Using this guiding motto, Nanogate AG launched a comprehensive innovation offensive in 2009 in order to open up new growth prospects for its clients. To achieve this, Nanogate increased its investments and funding significantly - in particular in the 2009 financial year - and has since then presented a multitude of innovations. Since going public in 2006 the company has already invested several million euros in developing new technology platforms and has transformed these into marketable products. Nanogate has successfully illustrated its expertise in more than 180 cases, using innovations to provide its clients with a competitive advantage.
About sarastro GmbH
The nanotech company sarastro GmbH specialises in developing and marketing biologically active functional surface finishes. Established in 2001, sarastro offers innovative solutions based on chemical nanotechnology for applications from the fields of medicine, medical technology, life science, hygiene, cosmetics and food. The company’s customers include Wincor-Nixdorf and Siemens. The firm currently has twelve employees, most of whom are scientists (chemists, biologists and doctors).
The company’s own chemical and biological laboratories are crucial to successfully developing and marketing new solutions. They enable sarastro to check that newly developed materials comply both with standard technical requirements and with biological and medical compatibility specifications. Quality-controlled production is guaranteed by a quality management system in accordance with DIN EN ISO 13485:2007 and Annex V 93/42/EEC. As well as guaranteeing top-quality development, sarastro thus ensures that newly developed materials are produced to the high standard expected in the industry.
For more information, please click here
Christian Dose (financial press and investors)
Cortent Kommunikation AG
Tel. +49 (0)69 5770 300-0
Karen Kumposcht (business and trade press)
MPW FINANCE Public & Investor Relations GmbH
Tel. +49 (0)69 9592 90-12
Zum Schacht 3
Copyright © Nanogate AGIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015
Graphenea celebrates fifth anniversary April 27th, 2015
How can you see an atom? (video) April 10th, 2015